Mast cell activation syndrome (MCAS) is a condition in which mast cells — immune cells found throughout the skin, gut, airways, and blood vessels — release inflammatory chemical mediators too easily or too often, in response to triggers that wouldn't normally cause a reaction. The result is a pattern of recurring, often unpredictable symptoms that can affect nearly every organ system at once: flushing, hives, abdominal pain, diarrhea, wheezing, and lightheadedness, frequently set off by foods, temperature changes, stress, exercise, or strong smells. Because MCAS symptoms are so varied and overlap with dozens of other conditions, people often see multiple specialists over years before receiving a diagnosis — if they receive one at all. A 2025 anonymous survey study, comparing 553 people with MCAS to 558 matched controls, set out to measure something rarely studied directly: how often this unpredictable, body-wide illness is also accompanied by a heavy burden of anxiety, depression, and other psychiatric symptoms.
What the Research Shows
Researchers surveyed 553 people with MCAS (499 women and 54 men) and 558 people without the condition, asking about a wide range of neurologic and psychiatric diagnoses and symptoms, then calculated odds ratios adjusting for age and gender. The differences were stark and consistent across both genders. Among women, 65.9% of MCAS patients reported an anxiety disorder, compared to 30.3% of controls (more than 4 times the odds), and 58.7% reported depression, compared to 30.3% of controls (3 times the odds). Rates of panic disorder (48.7% vs. 20.0%), PTSD (48.3% vs. 12.0%, more than 6 times the odds), and suicidal thoughts (33.9% vs. 6.7%, more than 7 times the odds) were all significantly higher as well. Among men, the pattern was just as clear: anxiety disorder affected 49.1% of MCAS patients versus 20.8% of controls, depression affected 54.4% versus 20.1%, PTSD affected 26.3% versus 4.2% (more than 8 times the odds), and suicidal thoughts affected 19.3% versus 3.5%. On average, women with MCAS reported living with 3.8 distinct psychiatric conditions, compared to 1.3 among female controls; men with MCAS reported 2.9, compared to 0.9 among male controls — all differences highly statistically significant.
Ways to Cope
- Treat the psychological symptoms as part of the same underlying condition, not a separate problem. Mast cell mediators like histamine can act directly on the brain and nervous system, so anxiety, panic, and mood changes during a flare may be a physiological symptom of MCAS itself, not “just” worry about being sick — understanding this can reduce self-blame.
- Build a care team that includes both an MCAS specialist and a mental health provider. Because MCAS crosses so many body systems, no single specialist typically manages it alone; adding a therapist or psychiatrist willing to coordinate with your physical-health team, rather than treating your anxiety or depression in isolation, better matches how intertwined these symptoms really are.
- Keep a trigger-and-symptom log that includes mood, not just physical symptoms. Many people with MCAS already track foods, temperatures, or activities that trigger flares; adding a quick note on anxiety, panic, or mood each day can help you and your clinicians see whether psychiatric symptoms cluster around flares, which can guide both physical and mental-health treatment.
- If a benzodiazepine is suggested for anxiety, ask about both its benefits and its dependence risk. In this same survey, patients who'd tried benzodiazepines rated them as more effective for anxiety than antihistamines or low-dose naltrexone; that can be useful information to bring to a prescriber, but benzodiazepines also carry a real risk of tolerance and dependence with long-term use, so it's worth discussing a plan for monitoring and duration explicitly.
- Prepare for appointments where your psychiatric symptoms might be dismissed as “just anxiety about being sick.” Bringing a brief written symptom and trigger timeline can help steer the conversation back to the physiological burden of MCAS, rather than leaving mood symptoms to be explained away as understandable stress.
A Large Sample, With Honest Limitations
This survey offers an unusually large, matched-control comparison for a condition where controlled psychiatric data is otherwise scarce, and the gap between patients and controls held up strongly across nearly every disorder measured, for both women and men. Still, it has real limits worth naming. It was an anonymous, self-selected, computer-based survey, not a clinical sample drawn through random referral, so people who felt strongly affected by MCAS may have been more likely to participate, and no physician or chart review could confirm the self-reported diagnoses, treatments, or outcomes. The study's gender makeup — 90% of MCAS patients were women — mirrors what's reported elsewhere in MCAS research generally, thought to relate to estrogen's effects on mast-cell receptors, so it likely reflects the real patient population rather than a sampling flaw unique to this study. The COVID-19 pandemic may also have influenced results, since infections are known to be able to flare MCAS symptoms or produce overlapping Long COVID symptoms in some patients. Finally, the ratings of how well antihistamines, low-dose naltrexone, and benzodiazepines worked came from patients' own retrospective impressions, not a controlled trial, so they show what patients found subjectively helpful rather than proof that any one treatment causally works better than another. One of the paper's eleven co-authors has a financial relationship with a mast-cell-focused company, a disclosure worth knowing about.
You're Not Alone
If you're navigating MCAS, the challenges involved often overlap with ground covered elsewhere on this site. Because MCAS is frequently dismissed or misdiagnosed by clinicians unfamiliar with it, our page on Medical Gaslighting may help validate that experience and offer ways to advocate for yourself. For the wider experience of living with an unpredictable, multi-system illness, our guide to Living with Chronic Illness or Pain offers additional coping tools, and because MCAS flares often involve pain, our page on Coping with Chronic Pain may also help. MCAS also shares much with other poorly understood, symptom-cluster conditions that are often invisible to others, and our page on Fibromyalgia covers closely related emotional territory.
Tips for Supporting Someone With MCAS
- Don't dismiss MCAS as “just allergies.” MCAS involves inappropriate release of inflammatory chemicals that can affect the skin, gut, heart, lungs, and brain all at once, often with no obvious external trigger — it's a serious, body-wide condition, not a mild sensitivity.
- Take mood symptoms as seriously as physical ones. This research found MCAS patients were several times more likely to experience anxiety, depression, panic attacks, PTSD, and suicidal thoughts than people without the condition; asking directly about mood, not just physical flares, can open a door that purely physical check-ins don't.
- Offer specific, practical help rather than a general “let me know if you need anything.” Because triggers can include food, temperature, strong scents, and physical exertion, concrete offers — helping plan a fragrance-free gathering, double-checking a recipe's ingredients, or just sitting with someone during a flare — are easier to use than open-ended offers.
- Believe the diagnosis, even if it's unfamiliar to you. MCAS is a relatively newly recognized condition that many clinicians themselves don't fully understand yet, and people with it often face skepticism or repeated dismissal before being taken seriously; your belief can matter as much as any treatment.
- Know that effective treatment is possible, but may take time and several providers to find. In this research, roughly half of those affected by anxiety or depression weren't receiving any treatment for it, often because the same medical complexity that makes MCAS hard to diagnose also makes it hard to find clinicians equipped to treat its psychiatric side — persistence tends to pay off.